In this exciting series: “Structural heart disease: the revolution”, some of the greatest experts of the world review the state of the art of these therapies and devices, share future challenges and publish interesting works.
Preface
Structural heart disease: the revolution
Aortic valve
Long term follow up of percutaneous treatment for degenerated Mitroflow prosthesis with self-expanding transcatheter aortic valve implantation
Transcatheter aortic valve replacement (TAVR): expanding indications to low-risk patients
Choice of transcatheter heart valve: should we select the device according to each patient’s characteristics or should it be “one valve fits all”?
Mitral valve
Ventricular arrhythmias in patients with functional mitral regurgitation and implantable cardiac devices: implications of mitral valve repair with Mitraclip®
Initial experience of a MitraClip valve repair program in Spain
Functional mitral regurgitation: structural modifications with percutaneous valve repair with MitraClip
Percutaneous treatment with Mitraclip for functional mitral regurgitation: medium-term follow up according to left ventricular function
Outcomes with percutaneous mitral repair vs. optimal medical treatment for functional mitral regurgitation: systematic review
Percutaneous mitral repair: current and future devices
Past, current and future management of secondary mitral valve disease: the importance of anatomic staging
Tricuspid valve
Catheter-based treatment of tricuspid regurgitation: state of the art
Fusion imaging for transcatheter mitral and tricuspid interventions
Pulmonary valve
Pulmonary regurgitation after repaired tetralogy of Fallot: surgical versus percutaneous treatment
Miscellany
Tetralogy of Fallot: cardiac imaging evaluation
Disclosure:
The series “Structural Heart Disease: The Revolution” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Daniel Hernandez-Vaquero served as the unpaid Guest Editor for the series.